Large-scale testing (Phase 3)Study completedNCT04614948
What this trial is testing
Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults
Who this might be right for
Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19
Janssen Vaccines & Prevention B.V. 31,835